UNITY BIOTECHNOLOGY INC (UBXXXXX)
Institutional ownership reported to the SEC as of Q4 2022, across 17 quarters.
2
Reporting holders
$431.3K
Reported value
0.0%
Held as options
-57
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Mayo Clinic | $430.7K | 157,198 | 0.23% | 8q | -90.0%-$3.9M |
| Rosenberg Matthew Hamilton | $548 | 200 | 0.00% | 8q | -90.0%-$4.9K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2022 | 2 | $431.3K | 157,398 | 0 | 0 | 2 | 0.0% |
| Q3 2022 | 59 | $25.3M | 50,551,021 | 22 | 15 | 8 | 21.0% |
| Q2 2022 | 57 | $5.9M | 9,418,874 | 11 | 16 | 16 | 10.1% |
| Q1 2022 | 63 | $15.2M | 12,622,779 | 10 | 14 | 19 | 7.0% |
| Q4 2021 | 66 | $22.2M | 14,972,445 | 14 | 20 | 12 | 1.7% |
| Q3 2021 | 77 | $42.4M | 13,761,016 | 6 | 17 | 29 | 0.7% |
| Q2 2021 | 94 | $84.8M | 18,119,265 | 29 | 16 | 24 | 0.8% |
| Q1 2021 | 88 | $123.0M | 20,307,044 | 16 | 19 | 25 | 1.0% |
| Q4 2020 | 80 | $111.1M | 20,991,749 | 16 | 35 | 11 | 1.0% |
| Q3 2020 | 79 | $69.9M | 19,691,009 | 20 | 22 | 23 | 1.2% |
| Q2 2020 | 82 | $216.6M | 24,921,363 | 20 | 31 | 14 | 0.1% |
| Q1 2020 | 73 | $127.1M | 21,903,814 | 8 | 21 | 21 | 0.0% |
| Q4 2019 | 78 | $159.7M | 22,151,283 | 19 | 32 | 10 | 0.0% |
| Q3 2019 | 62 | $99.7M | 16,338,912 | 11 | 19 | 18 | 0.0% |
| Q2 2019 | 57 | $157.6M | 16,590,119 | 13 | 23 | 9 | 0.0% |
| Q1 2019 | 56 | $133.0M | 16,392,461 | 11 | 22 | 13 | 0.1% |
| Q4 2018 | 54 | $259.9M | 15,984,273 | 3 | 1 | 1 | 0.0% |